Straits Times Index
3,330.09 +11.64 (+0.35%) S&P 500
5,301.45 -3.27 (-0.06%) Dow
38,797.79 -271.80 (-0.70%) Nasdaq
17,007.58 +86.79 (+0.51%) Bitcoin USD
67,837.55 -2,278.72 (-3.25%) CMC Crypto 200
1,471.93 -24.53 (-1.64%)
EXAS Oct 2024 37.500 put
| Previous close | 1.0000 |
| Open | 1.6900 |
| Bid | 1.6500 |
| Ask | 1.9000 |
| Strike | 37.50 |
| Expiry date | 2024-10-18 |
| Day's range | 1.6900 - 1.6900 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.85k |
ZacksExact Sciences (EXAS) to Showcase Favorable Research Outcome
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
Business WireExact Sciences to Participate in June Investor Conferences
MADISON, Wis., May 28, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
Insider MonkeyHedge Funds are Bullish on This Cancer Stock
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation (NASDAQ:EXAS). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]
